Nitorum Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-69,626
| Closed | -$19M | – | 29 |
|
|
2024
Q2 | $19M | Sell |
69,626
-42,027
| -38% | -$11.5M | 2.07% | 24 |
|
|
2024
Q1 | $38.6M | Sell |
111,653
-23,251
| -17% | -$8.04M | 3.93% | 10 |
|
|
2023
Q4 | $43.6M | Sell |
134,904
-17,529
| -11% | -$5.66M | 4.66% | 8 |
|
|
2023
Q3 | $54.6M | Sell |
152,433
-29,420
| -16% | -$10.5M | 5.97% | 3 |
|
|
2023
Q2 | $68.9M | Buy |
181,853
+27,617
| +18% | +$10.5M | 6.97% | 3 |
|
|
2023
Q1 | $73.9M | Sell |
154,236
-66,021
| -30% | -$31.6M | 7.83% | 2 |
|
|
2022
Q4 | $92.6M | Buy |
220,257
+14,800
| +7% | +$6.22M | 8.73% | 1 |
|
|
2022
Q3 | $85.7M | Buy |
205,457
+17,000
| +9% | +$7.09M | 7.46% | 2 |
|
|
2022
Q2 | $93.3M | Buy |
188,457
+77,900
| +70% | +$38.6M | 6.87% | 3 |
|
|
2022
Q1 | $62.3M | Buy |
+110,557
| New | +$62.3M | 4.13% | 9 |
|